+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of retained surgical sponges: a decision-analytic model predicting relative cost-effectiveness



Prevention of retained surgical sponges: a decision-analytic model predicting relative cost-effectiveness



Surgery 145(5): 527-535



New technologies are available to reduce or prevent retained surgical sponges (RSS), but their relative cost effectiveness are unknown. We developed an empirically calibrated decision-analytic model comparing standard counting against alternative strategies: universal or selective x-ray, bar-coded sponges (BCS), and radiofrequency-tagged (RF) sponges. Key model parameters were obtained from field observations during a randomized-controlled BCS trial (n = 298), an observational study of RSS (n = 191,168), and clinical experience with BCS (n approximately 60,000). Because no comparable data exist for RF, we modeled its performance under 2 alternative assumptions. Only incremental sponge-tracking costs, excluding those common to all strategies, were considered. Main outcomes were RSS incidence and cost-effectiveness ratios for each strategy, from the institutional decision maker's perspective. Standard counting detects 82% of RSS. Bar coding prevents > or =97.5% for an additional $95,000 per RSS averted. If RF were as effective as bar coding, it would cost $720,000 per additional RSS averted (versus standard counting). Universal and selective x-rays for high-risk operations are more costly, but less effective than BCS-$1.1 to 1.4 million per RSS event prevented. In sensitivity analyses, results were robust over the plausible range of effectiveness assumptions, but sensitive to cost. Using currently available data, this analysis provides a useful model for comparing the relative cost effectiveness of existing sponge-tracking strategies. Selecting the best method for an institution depends on its priorities: ease of use, cost reduction, or ensuring RSS are truly "never events." Given medical and liability costs of >$200,000 per incident, novel technologies can substantially reduce the incidence of RSS at an acceptable cost.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055170138

Download citation: RISBibTeXText

PMID: 19375612

DOI: 10.1016/j.surg.2009.01.011


Related references

Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model. European Journal of Health Economics 15(8): 869-883, 2015

A decision analytic model to investigate the cost-effectiveness of poisoning prevention practices in households with young children. Bmc Public Health 15: 705-705, 2017

Cost-effectiveness of orthoptic screening in kindergarten: a decision-analytic model. Strabismus 8(2): 79-90, 2000

Cost-effectiveness of abciximab after coronary stenting A decision-analytic model. Journal of the American College of Cardiology 31(2 SUPPL A): 51A, 1998

Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Human Reproduction 24(7): 1648-1655, 2009

Cost effectiveness of combination therapy for hepatitis C: A decision analytic model. Gut 50(2): 253-258, February, 2002

Cost effectiveness of perioperative beta blockade A decision analytic model. Anesthesia & Analgesia 94(2S Supplement): S 61, February, 2002

Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands. Journal of Clinical Psychiatry 72(1): 51-59, 2011

Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques. European Journal of Clinical Nutrition 53 Suppl 2: S25-S28, 1999

Cost-effectiveness of regulations restricting cellular telephone use while driving A decision analytic model. Jgim 12(Suppl 1): 62, 1997

Cost-effectiveness of pergolide compared to bromocriptine in the treatment of Parkinson's disease: a decision-analytic model. Value in Health 4(4): 308-315, 2001

Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model. Fertility and Sterility 96(4): 889-894, 2011

The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic model. Bmc Health Services Research 12(): 418-418, 2013